Skip to main content

Market Overview

14 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 336.1% to $35.15 during Tuesday's pre-market session. The market value of their outstanding shares is at $501.1 million. The most recent rating by Raymond James, on November 26, is at Strong Buy, with a price target of $56.00.
  • InflaRx, Inc. (NASDAQ: IFRX) stock moved upwards by 13.2% to $3.00. The market value of their outstanding shares is at $69.1 million.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) shares moved upwards by 12.6% to $0.16. The market cap stands at $4.3 million.
  • Global Blood Therapeutics, Inc. (NASDAQ: GBT) stock increased by 11.6% to $67.00. The market value of their outstanding shares is at $2.8 billion. The most recent rating by Nomura, on November 26, is at Buy, with a price target of $112.00.
  • VBI Vaccines, Inc. (NASDAQ: VBIV) shares moved upwards by 6.8% to $0.73. The market value of their outstanding shares is at $104.2 million. The most recent rating by Raymond James, on November 14, is at Outperform, with a price target of $3.00.
  • Mallinckrodt, Inc. (NYSE: MNK) shares moved upwards by 5.0% to $3.78. The market cap seems to be at $265.6 million. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.

 

Losers

  • ASLAN Pharmaceuticals, Inc. (NASDAQ: ASLN) stock plummeted 16.4% to $1.07 during Tuesday's pre-market session. The market cap seems to be at $49.3 million. The most recent rating by H.C. Wainwright, on November 14, is at Buy, with a price target of $2.00.
  • Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) stock declined 10.2% to $3.70. The market cap seems to be at $8.3 million.
  • Kazia Therapeutics, Inc. (NASDAQ: KZIA) shares declined 7.7% to $5.18. The market cap seems to be at $23.9 million.
  • Canopy Growth, Inc. (NYSE: CGC) shares fell 2.8% to $17.90. The market cap seems to be at $6.9 billion. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
  • Aurora Cannabis, Inc. (NYSE: ACB) stock fell 2.8% to $2.44. The market cap seems to be at $3.6 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) shares plummeted 2.7% to $9.99. The market value of their outstanding shares is at $173.7 million. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
  • Genmab, Inc. (NASDAQ: GMAB) shares declined 1.4% to $23.45. The market cap seems to be at $14.1 billion. The most recent rating by HC Wainwright & Co., on October 16, is at Buy, with a price target of $25.00.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) stock decreased by 1.0% to $3.08. The market value of their outstanding shares is at $215.6 million. The most recent rating by JMP Securities, on October 07, is at Market Outperform, with a price target of $21.00.
 

Related Articles (ACB + ASLN)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com